Skip to content

Effect of low concentration ropivacaine nerve block on laser intraluminal occlusion of great saphenous vein varicose hemangioma

Effect of low concentration ropivacaine nerve block on laser intraluminal occlusion of great saphenous vein varicose hemangioma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107100
Enrollment
Unknown
Registered
2025-08-04
Start date
2025-08-04
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Great saphenous vein varicose

Interventions

Femoral nerve block group:Under ultrasound guidance, 20ml of 0.15% ropivacaine was injected into the femoral nerve peripherally in the plane
Spin-hard combined group:The procedure included lumbar joint puncture and subarachnoid injection of 2ml of 0.75% ropivacaine

Sponsors

Jinjiang Hospital (Fujian Hospital of Shanghai Sixth People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) grade I.~III 2. Proposed intraluminal laser closure of the great saphenous vein 3. Age 18-75 years old 4.BMI:18-30 kg/m^2

Exclusion criteria

Exclusion criteria: 1. Pregnant women, patients with mental illness or unable to cooperate 2. There is an infection in the operating area 3. Allergy to local anesthetics 4. Patients with COPD and other respiratory diseases, coagulation dysfunction and other serious systemic diseases 5. Those who have numbness in the lower limbs before surgery 6. Patients who drop out of the trial midway

Design outcomes

Primary

MeasureTime frame
VAS grade;Postoperative anesthesia;

Secondary

MeasureTime frame
Changes in hemodynamics;

Countries

China

Contacts

Public ContactFengyi Lin

Jinjiang Hospital (Fujian Hospital of Shanghai Sixth People's Hospital)

252468507@qq.com+86 135 9972 5599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026